Price
Financials
Consolidated, Rs crore| Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 28 | 39 | 35 | 47 | 31 | 38 | 31 | 33 | 62 | 19 | 12 | 17 |
| Operating costs | 23 | 34 | 28 | 44 | 30 | 32 | 24 | 28 | 51 | 20 | 17 | 20 |
| EBITDA | 4 | 5 | 7 | 3 | 1 | 5 | 7 | 4 | 11 | -1 | -5 | -3 |
| EBITDA margin % | 15% | 13% | 20% | 7% | 2.9% | 14% | 22% | 14% | 18% | -8% | -44% | -18% |
| Depreciation & amortisation | 3 | 2 | 1 | 2 | 2 | 3 | 3 | 3 | 5 | 2 | 2 | 2 |
| Finance costs | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 6 | 2 | 1 | 0 |
| Non-operating income | 1 | -0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | -12 | 0 | -13 |
| Pre-tax profit | -2 | -1 | 2 | -2 | -4 | 0 | 2 | -1 | 0 | -18 | -8 | -18 |
| Effective tax rate % | 17% | 23% | 28% | 7% | -13% | -167% | 14% | 37% | -400% | 0% | -0% | 0% |
| Profit after tax | -2 | -1 | 1 | -2 | -4 | 0 | 2 | -1 | 0 | -18 | -8 | -18 |
| Earnings per share (Rs) | -0.75 | -0.46 | 0.48 | -0.72 | -1.54 | 0.19 | 0.62 | -0.59 | 0.10 | -7.30 | -3.09 | -7.19 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Revenue from operations | 57 | 74 | 78 | 69 | 62 | 31 | 28 |
| Operating costs | 50 | 62 | 74 | 56 | 51 | 37 | 35 |
| EBITDA | 7 | 12 | 4 | 13 | 11 | -7 | -7 |
| EBITDA margin % | 13% | 16% | 6% | 19% | 18% | -21% | -23% |
| Depreciation & amortisation | 4 | 3 | 4 | 5 | 5 | 4 | 4 |
| Finance costs | 7 | 8 | 7 | 6 | 6 | 3 | 1 |
| Non-operating income | 1 | 0 | 0 | 1 | 0 | -12 | -12 |
| Pre-tax profit | -4 | 1 | -6 | 2 | 0 | -26 | -23 |
| Effective tax rate % | 7% | 91% | -8% | -2% | -1,600% | -0% | 0% |
| Profit after tax | -4 | 0 | -6 | 2 | 1 | -26 | -23 |
| Earnings per share (Rs) | -1.62 | 0.02 | -2.21 | 0.81 | 0.34 | -10.39 | -9.32 |
| Paid out as dividend % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Revenue CAGR | % | -17% | -26% | -8% | ||
| Profit CAGR | % | % | % | 27% | ||
| Share price CAGR | % | 4% | 6% | 376% | ||
| Average return on equity | % | -11% | -19% | -49% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Net block (property, plant) | 39 | 37 | 50 | 45 | 39 | 35 | 32 |
| Capital work in progress | 25 | 26 | 13 | 14 | 15 | 15 | 6 |
| Investments | 5 | 5 | 5 | 5 | 5 | 5 | 0 |
| Current & other assets | 87 | 90 | 98 | 97 | 102 | 101 | 23 |
| Total assets | 157 | 157 | 166 | 160 | 161 | 156 | 62 |
| Share capital | 23 | 23 | 25 | 25 | 25 | 25 | 25 |
| Reserves & surplus | 35 | 35 | 30 | 32 | 33 | 7 | -16 |
| Total debt | 73 | 71 | 63 | 61 | 56 | 55 | 29 |
| Other liabilities & provisions | 25 | 28 | 47 | 42 | 47 | 69 | 24 |
| Equity + liabilities | 157 | 157 | 166 | 160 | 161 | 156 | 62 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -7 | 6 | 9 | 5 | 12 | 21 | -1 |
| Investing cash flow | -27 | 3 | 1 | 3 | -1 | -0 | 13 |
| Free cash flow (after capex) | -26 | 4 | 4 | 4 | 11 | 20 | 7 |
| Financing cash flow | 36 | -10 | -11 | -7 | -10 | -4 | -28 |
| Net change in cash | 1 | -1 | -1 | -0 | -0 | 17 | -17 |
| Cash conversion (OCF / EBITDA) % | -99% | 49% | 197% | 37% | 106% | -315% | 22% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Return on capital employed % | 7% | 0% | 7% | 5% | -11% | -15% | |
| Receivable days | 128 | 94 | 125 | 140 | 121 | 206 | 163 |
| Inventory days | 214 | 277 | 300 | 400 | 486 | 420 | 82 |
| Payable days | 176 | 186 | 270 | 296 | 371 | 671 | 219 |
| Cash cycle (days) | 166 | 185 | 155 | 244 | 236 | -45 | 26 |
| Working capital days | 15 | 16 | 38 | 41 | 26 | -729 | -96 |
| Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter group % | 66.26% | 66.26% | 66.26% | 66.26% | 51.85% | 49.62% | 27.10% | 27.10% | 27.11% | 27.11% | 27.11% | 95.00% |
| Domestic institutions % | 0.00% | 0.00% | 0.00% | 0.79% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Retail & others % | 33.74% | 33.74% | 33.75% | 32.96% | 48.16% | 50.39% | 72.90% | 72.90% | 72.90% | 72.89% | 72.89% | 5.00% |
| Shareholder count | 396 | 392 | 424 | 418 | 454 | 672 | 880 | 831 | 1,088 | 1,501 | 1,662 | 1,683 |
Fundamentals
Market value₹ 61.2 Cr.
Last price₹ 24.5
Book value / share₹ 3.42
Return on capital-15.1 %
Return on equity-49.2 %
Dividend yield0.00 %
Face value₹ 10.0
Revenue CAGR (TTM)-8%
Profit CAGR (TTM)27%
Consolidated figures.
Valuation
Market capRs 65 Cr
Enterprise valueRs 124 Cr
P/E (TTM)31.95x
Price to book1.13x
Price to sales0.95x
EV / EBITDA9.06x
EV / EBIT15.00x
EV / sales1.81x
Price to cash flow13.40x
Earnings yield3.13%
P/E, 3-year average280.05x
P/B, 3-year average0.84x
Profitability
Operating margin (excl. other income)18.94%
Operating margin (incl. other income)20.00%
EBITDA margin20.00%
Pre-tax margin2.90%
Net profit margin2.96%
ROE3.59%
ROCE7.00%
ROA1.24%
ROE, 3-year average-2.02%
ROCE, 3-year average4.69%
ROA, 3-year average-0.72%
ROIC (approx.)7.23%
Tax rate-2.01%
Other income / net worth1.27%
Growth
Sales growth (latest year)-11.92%
Sales CAGR, 3 years6.31%
Per share
EPS (TTM)Rs 0.81
EPS (latest year)Rs 0.81
EPS, 3-year averageRs -0.46
Book value per shareRs 23.00
Sales per shareRs 27.44
Cash flow per shareRs 1.94
Free cash flow per shareRs 2.80
Efficiency
Asset turnover0.43x
Fixed asset turnover1.54x
Inventory turnover1.09x
Inventory days334 days
Debtor days140 days
Debtors turnover2.61x
Creditor days219 days
Cash conversion cycle26 days
Working capital days-96 days
Leverage
Total debtRs 61 Cr
Cash and bankRs 1 Cr
Net debtRs 59 Cr
Debt to equity1.06x
Net debt / EBITDA4.34x
Interest coverage1.32x
Owners' fund to total sources35.82%
Debt to assets37.89%
Cash flow
Operating cash flow (latest year)Rs 5 Cr
Investing cash flow (latest year)Rs 3 Cr
Financing cash flow (latest year)Rs -7 Cr
Net change in cash (latest year)Rs -0 Cr
Free cash flow (latest year)Rs 7 Cr
FCFE (approx.: FCF + change in debt)Rs 5 Cr
Sales to cash flow14.17x
Statement figures
Net sales (TTM)Rs 69 Cr
Net sales (latest year)Rs 69 Cr
Operating profit excl. other income (latest year)Rs 13 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs 14 Cr
PBDT (TTM)Rs 7 Cr
Profit before tax (TTM)Rs 2 Cr
Tax (latest year)Rs -0 Cr
Net profit (TTM)Rs 2 Cr
Net profit (latest year)Rs 2 Cr
Depreciation (TTM)Rs 5 Cr
Interest (TTM)Rs 6 Cr
Cost of goods sold (latest year)Rs 40 Cr
Total expenditure (latest year)Rs 56 Cr
Total income (latest year)Rs 69 Cr
Share capitalRs 25 Cr
ReservesRs 32 Cr
Shareholders' fundsRs 57 Cr
Total assetsRs 160 Cr
Net blockRs 45 Cr
Capital work in progressRs 14 Cr
InvestmentsRs 5 Cr
ReceivablesRs 26 Cr
InventoryRs 37 Cr
Other liabilitiesRs 42 Cr
Shares outstanding (crore)2.50
Ownership
Promoter holding95.00% (+67.90 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/B 1.13 is at the 95th percentile (median 0.37).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 542678 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +10.3% | +0.4% | +9.8 pts |
| 1 month | +146.7% | -4.7% | +151.4 pts |
| 3 years | +25.1% | +14.4% | +10.7 pts |
| 5 years | +19.3% | +25.8% | -6.5 pts |
| Holder | Now | vs last qtr | vs 1 yr |
|---|---|---|---|
| Promoter group | 95.00% | +67.89 | +67.90 |
| Retail & others | 5.00% | -67.89 | -67.90 |
| Shareholders | 1,683 | +852 |
Changes in percentage points. Quarter Mar 2026.
Red flags
F-score 7 of 8| explain | Low interest cover Interest cover 1.3x in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹17 Cr -48.5% vs Sep 2023.
Net loss ₹18 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Cian Healthcare Ltd?
Cian Healthcare Ltd (542678) has a market capitalisation of Rs 61.2 Cr. at the 2026-10-09 close.
What were Cian Healthcare Ltd's latest quarterly results?
In the Mar 2026 quarter, Cian Healthcare Ltd sales was Rs 17 Cr (-48.5% vs Sep 2023) with a net loss of Rs 18 Cr.